Mylan launches first generic for Adcirca tablets
HERTFORDSHIRE, England and PITTSBURGH — Mylan N.V. announced the U.S. launch of tadalafil tablets USP, 20 mg, the first generic version of the reference listed drug, Eli Lilly and company’s Adcirca. Mylan Pharmaceuticals received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) and was awarded 180 days of
